CN Patent

CN114469882B — 一种右美沙芬奎尼丁口崩片及其应用

Assigned to Beijing Jitai Life Science Technology Co Ltd · Expires 2023-10-20 · 3y expired

What this patent protects

本发明提供一种右美沙芬奎尼丁口崩片、其制备方法和应用。该口崩片加入矫味剂以改善右美沙芬和奎尼丁味道极苦极麻的问题，且制得的口崩片易于崩解，解决了神经系统疾病患者吞咽困难问题的同时，大大改善了患者的用药体验。同时，本发明提供的右美沙芬奎尼丁口崩片制备工艺简单，适用于工业化大生产。

USPTO Abstract

本发明提供一种右美沙芬奎尼丁口崩片、其制备方法和应用。该口崩片加入矫味剂以改善右美沙芬和奎尼丁味道极苦极麻的问题，且制得的口崩片易于崩解，解决了神经系统疾病患者吞咽困难问题的同时，大大改善了患者的用药体验。同时，本发明提供的右美沙芬奎尼丁口崩片制备工艺简单，适用于工业化大生产。

Drugs covered by this patent

dextromethorphan-hydrobromide (DEXTROMETHORPHAN HYDROBROMIDE)

Patent Metadata

Patent number: CN114469882B
Jurisdiction: CN
Classification: —
Expires: 2023-10-20
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Jitai Life Science Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.